missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human HGF (NS0-expressed) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Marke: R&D Systems™ 294-HGN-025
521.80 EUR gültig bis 2024-12-16
Benutzen Sie den Promotions-Code "21630" um Ihren Promotions-Preis zu erhalten.
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
- Source: Mouse myeloma cell line, NS0-derived, Gln32-Ser728
- Purity: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
- Molecular Weight: alpha chain: 53.7 kDabeta chain: 26 kDa
- Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
- Entrez Gene ID: 3082
- Regulatory Status: RUO
Spezifikation
P14210.2 | |
3082 | |
HGF | |
Mouse myeloma cell line, NS0-derived human HGF protein Gln32-Ser728 (Asp384Asn, Asp416Asn, Leu622Ser, His645Arg, Val678Ile) | |
Disulfide-linked heterodimer | |
Unconjugated | |
95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. | |
Predicted MW: alpha chain: 53.7kDa beta chain: 26kDa Observed MW: 65-75kDa, non-reducing conditions 60-65kDa and 30-40kDa, reducing conditions | |
25 μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
deafness, autosomal recessive 39, DFNB39, EC 3.4.21, EC 3.4.21.7, fibroblast-derived tumor cytotoxic factor, F-TCF, hepatocyte growth factor (hepapoietin A; scatter factor), Hepatopoeitin-A, Hepatopoietin A, HGFB, HPTA, HPTAhepatocyte growth factor, lung fibroblast-derived mitogen, Scatter factor, SF, SFhepatopoeitin-A | |
Recombinant |